Sanctuary Sites: What Lies behind Ebola Eye Infections, Sexual Transmission, and Relapses

Health Security

Volumn 13, Issue 6, 2015, Pages 396-398

  Adalja, Amesh A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CENTRAL NERVOUS SYSTEM; DISEASE CARRIER; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EYE INFECTION; HUMAN; PATHOGENICITY; RECURRENT DISEASE; SEXUALLY TRANSMITTED DISEASE; TRANSMISSION; VIROLOGY;

CENTRAL NERVOUS SYSTEM; DISEASE RESERVOIRS; EBOLAVIRUS; EYE INFECTIONS; HEMORRHAGIC FEVER, EBOLA; HUMANS; RECURRENCE; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 84982786490     PISSN: 23265094     EISSN: 23265108     Source Type: Journal    
DOI: 10.1089/hs.2015.28999.aaa     Document Type: Article

References (11)

1. Bosely S. How Pauline Cafferkey's Ebola relapse tears up everything doctors thought. Guardian October 16, 2015. http://www.theguardian.com/world/2015/oct/16/how-paulinecafferkeys-ebola-relapse-tears-up-everything-doctors-thoughtthey-knew. Accessed November 4, 2015.
2. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 2015; 372(25):2423-2427.
3. Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 2015. http://www.nejm.org/doi/full/10.1056/NEJMe15129 28#t=article. Accessed November 4, 2015.
4. Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S; EORTC Radiation Oncology Group and Lung Cancer Group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357(7):664-672.
5. Howlett P, Brown C, Helderman T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone [letter]. Emerg Infect Dis 2016;22(1). http://dx.doi.org/10.3201/eid2201.151212. Accessed November 4, 2015.
6. BwakaMA, BonnetMJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients. J Infect Dis 1999;179(Suppl 1):S1-S7.
7. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196(Suppl 2):S142-S147.
8. Deen GF, Knust B, Broutet N, et al. Ebola RNA persistence in semen of Ebola virus disease survivors-preliminary report. N Engl J Med 2015 Oct 14. http://www.nejm.org/doi/full/10.1056/NEJMoa1511410. Accessed November 4, 2015.
9. Qiu X, Audet J, Wong G, et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep 2013;3:3365.
10. Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014;514(7520):47-53.
11. Kugelman JR, Kugelman-Tonos J, Ladner JT, et al. Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail. Cell Rep 2015;12(12):2111-2120.